Market Cap
$3.8B
NVST
Envista Holdings Corp
$23.46 ▲ +1.30%
Prev close $23.16Market cap$3.8B
ConsensusHold
12-mo target$30.00 (+27.9%)
▲ Bullish
Analyst conviction 6/10
35 New Institutional Positions15 Institutional Exits Healthcare & Medical Devices
Snapshot
The big-picture read on NVST right now — valuation, ownership and activity at a glance.
Cap Size
Mid Cap
Analyst Consensus
Buy (55%)
Inst. Holders
50 funds
Inst. Value
$4.0B
Inst. Activity
35 buys / 15 sells
Insider Activity
$0.00 buy / $510.3K sell
Insider Net $
-$510.3K
SEC Reports
3
Price chart 30d -15.0%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 1, 2026 short_volume
Short Volume: NVST — 57.8% short (0.5M / 0.8M)
Short: 478,962 | Exempt: 24,900 | TRF Vol: 828,584 | Short Ratio: 57.8% | Off-exchange volume (dark
Aug 25, 2026 Insider
Hammes Eric D. surrendered for taxes 10,885 shares
Chief Financial Officer @ $27.47 ($299.0K)
Aug 25, 2026 Insider
Nilsson Stefan surrendered for taxes 804 shares
President, Nobel Biocare @ $27.47 ($22.1K)
Aug 25, 2026 Insider
Aug 19, 2026 SEC Befidi Robert surrendered for taxes 5,147 shares
President, Diagnostics @ $27.47 ($141.4K)
Envista Holdings appointed CEO Paul Keel as Chairman of the Board and granted him a $10M special equity award ($5M RSUs
8-K — Impact 3/10
Jun 30, 2026 Inst.
MORGAN STANLEY — TRIM
6,436,043 shares ($169.6M)
Jun 30, 2026 Inst.
Jun 3, 2026 SEC ARROWSTREET CAPITAL, LIMITED PARTNERSHIP — ADD
4,847,940 shares ($127.7M)
Envista disclosed the planned retirement of Chief Accounting Officer Faez Kaabi effective August 6, 2026, and the appoin
8-K — Impact 2/10
Analyst ratings buy % +14.6%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
55% rate it Buy or better · 22 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Sep 28, 2026 | BMO Capital | MAINTAIN | Market Perform | 53% |
| Sep 18, 2026 | Piper Sandler | REITERATE | Neutral | 54% |
| Sep 18, 2026 | UBS | MAINTAIN | Neutral | 55% |
| Sep 18, 2026 | Needham | REITERATE | Hold | 50% |
| Sep 3, 2026 | JP Morgan | UPGRADE | Overweight | 55% |
| Aug 6, 2026 | Piper Sandler | REITERATE | Neutral | 54% |
| Jul 29, 2026 | Piper Sandler | MAINTAIN | Neutral | 54% |
| Jul 9, 2026 | BMO Capital | INITIATE | Market Perform | 53% |
| Jun 11, 2026 | Barclays | MAINTAIN | Overweight | 54% |
| May 7, 2026 | JP Morgan | MAINTAIN | Neutral | 55% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 7 | 5 | 10 | 0 | 0 | 55% | |
| Aug 1, 2026 | 7 | 5 | 10 | 0 | 0 | 55% | |
| Jul 1, 2026 | 7 | 5 | 9 | 0 | 0 | 57% | |
| Jun 1, 2026 | 7 | 5 | 9 | 0 | 0 | 57% | |
| May 1, 2026 | 7 | 5 | 9 | 0 | 0 | 57% | |
| Apr 1, 2026 | 7 | 5 | 8 | 0 | 0 | 60% | |
| Mar 1, 2026 | 7 | 5 | 9 | 0 | 0 | 57% | |
| Feb 1, 2026 | 5 | 5 | 11 | 0 | 0 | 48% |
Price targets
Where 13 covering analysts think NVST trades over the next 12 months.
$30.00 +27.9% upside Strong Buy
Current$23.46 Low$23.00 Median$31.00 High$35.00 13 analysts
$23.00$35.00
Analyst rating Buy· 2.1/5 as of Oct 2, 2026
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
3 SEC filing reports analyzed · 0 bullish, 0 bearish, 0 mixed, 3 neutral · avg impact 2.7/10.
NEUTRAL8-K3/10
Envista Holdings appointed CEO Paul Keel as Chairman of the Board and granted him a $10M special equ
Aug 19, 2026
NEUTRAL8-K2/10
Envista disclosed the planned retirement of Chief Accounting Officer Faez Kaabi effective August 6,
Jun 3, 2026
NEUTRALDEFA14A3/10
Envista Holdings Corp filed a definitive proxy statement (DEFA14A) for a shareholder vote, which is
Apr 7, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Oct 1, 2026
short_volume
Short Volume: NVST — 57.8% short (0.5M / 0.8M)
Short: 478,962 | Exempt: 24,900 | TRF Vol: 828,584 | Short Ratio: 57.8% | Off-exchange volume (dark pool + OTC)
Sep 30, 2026
short_volume
Short Volume: NVST — 61.3% short (0.4M / 0.6M)
Short: 371,070 | Exempt: 0 | TRF Vol: 605,321 | Short Ratio: 61.3% | Off-exchange volume (dark pool + OTC)
Sep 29, 2026
short_volume
Short Volume: NVST — 71.2% short (1.0M / 1.4M)
Short: 991,187 | Exempt: 4 | TRF Vol: 1,392,108 | Short Ratio: 71.2% | Off-exchange volume (dark pool + OTC)
Sep 28, 2026
short_volume
Short Volume: NVST — 58.5% short (0.5M / 0.9M)
Short: 520,885 | Exempt: 257 | TRF Vol: 889,714 | Short Ratio: 58.5% | Off-exchange volume (dark pool + OTC)
Sep 25, 2026
short_volume
Short Volume: NVST — 70.5% short (0.9M / 1.3M)
Short: 944,919 | Exempt: 0 | TRF Vol: 1,339,903 | Short Ratio: 70.5% | Off-exchange volume (dark pool + OTC)
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $0.36 | $0.34–$0.38 | 11.0% | -1.0% | 11↑ 1↓ | $0.7B | 14 |
| Next Q | $0.41 | $0.39–$0.42 | 6.9% | +0.5% | 13↑ 1↓ | $0.8B | 14 |
| Current FY | $1.53 | $1.50–$1.57 | 28.7% | -0.1% | 16↑ 0↓ | $2.9B | 15 |
| Next FY | $1.67 | $1.59–$1.77 | 8.8% | -0.1% | 16↑ 0↓ | $3.0B | 15 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $0.355 | — |
| 7d ago | $0.357 | -0.002 |
| 30d ago | $0.359 | -0.004 |
| 60d ago | $0.343 | +0.012 |
| 90d ago | $0.344 | +0.011 |
Institutional ownership
Which big funds own NVST (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $4.0B total value (151,938,912 shares) as of 2026-Q2. Top holders: BlackRock,, ARIEL, DIMENSIONAL. Net buying activity: 35 institutions added/increased vs 15 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| BlackRock, Inc. | 18,437,542 | $485.8M | 12.1% | — |
| ARIEL INVESTMENTS, LLC | 9,818,177 | $258.7M | 6.5% | — |
| DIMENSIONAL FUND ADVISORS LP | 9,566,949 | $252.1M | 6.3% | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 7,487,670 | $197.3M | 4.9% | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 7,337,916 | $193.4M | 4.8% | — |
| MORGAN STANLEY | 6,436,043 | $169.6M | 4.2% | TRIM -26.8% |
| STATE STREET CORP | 5,329,275 | $140.5M | 3.5% | — |
| ALLIANCEBERNSTEIN L.P. | 5,213,644 | $132.3M | 3.3% | — |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 4,847,940 | $127.7M | 3.2% | ADD +69.6% |
| FRANKLIN RESOURCES INC | 4,810,040 | $126.7M | 3.2% | — |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| MORGAN STANLEY | TRIM | 8,793,137 | 6,436,043 | -26.8% | $169.6M |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | ADD | 2,858,293 | 4,847,940 | +69.6% | $127.7M |
| Quantinno Capital Management LP | ADD | 2,694,970 | 4,194,886 | +55.7% | $110.5M |
| Neuberger Berman Group LLC | DOUBLED | 12,639 | 3,876,747 | +30572.9% | $102.2M |
| BANK OF AMERICA CORP /DE/ | ADD | 2,190,485 | 2,743,403 | +25.2% | $72.3M |
| UBS Group AG | DOUBLED | 780,957 | 2,120,131 | +171.5% | $55.9M |
| NORGES BANK | NEW | — | 2,051,894 | — | $54.1M |
| WELLINGTON MANAGEMENT GROUP LLP | DOUBLED | 61,055 | 1,686,415 | +2662.1% | $44.4M |
| Point72 Asset Management, L.P. | NEW | — | 1,563,395 | — | $41.2M |
| RENAISSANCE TECHNOLOGIES LLC | ADD | 1,208,165 | 1,520,565 | +25.9% | $40.1M |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
15 insiders, 35 transactions. Net -$510.3K — $0.00 bought, $510.3K sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 25, 2026 | Hammes Eric D. | Chief Financial Officer | TAX W/H | 10,885 | $27.47 | $299.0K |
| Aug 25, 2026 | Nilsson Stefan | President, Nobel Biocare | TAX W/H | 804 | $27.47 | $22.1K |
| Aug 25, 2026 | Befidi Robert | President, Diagnostics | TAX W/H | 5,147 | $27.47 | $141.4K |
| Aug 25, 2026 | Acurio Veronica | President, Orthodontics | TAX W/H | 7,710 | $27.47 | $211.8K |
| Aug 20, 2026 | Reis Mischa | SVP, Strategy & Bus. Dev. | SELL | 8,000 | $27.50 | $220.0K |
| Aug 18, 2026 | Keel Paul A | Chief Executive Officer | AWARD | 159,900 | — | — |
| Aug 18, 2026 | Hammes Eric D. | Chief Financial Officer | AWARD | 47,970 | — | — |
| Aug 18, 2026 | Keel Paul A | Chief Executive Officer | AWARD | 179,730 | — | — |
| May 25, 2026 | Keel Paul A | Chief Executive Officer | TAX W/H | 12,811 | $23.43 | $300.2K |
| May 19, 2026 | TSINGOS CHRISTINE A | Director | AWARD | 9,330 | — | — |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for NVST.
Shares short
10,210,406
Settlement Sep 15, 2026
Change vs prior
-10.3%
Semi-monthly cycle
Days to cover
4.0
At avg daily volume
Of shares outstanding
≈6.4%
Estimate — not % of float
All NVST filing & press-release reports (3)
- 8-K reportAug 19, 2026
- 8-K reportJun 3, 2026
- DEFA14A reportApr 7, 2026